Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
Industry Groups Get in Front of Potential Medicare Advantage Cuts
As progressives seek to keep some expansion of Medicare benefits in the president’s shrinking budget reconciliation package, industry-allied organizations have been...Read More -
Iowa Medicaid Director Refutes Managed Care Audit Results
As the Iowa Dept. of Human Services considers making changes to its managed Medicaid program, IA Health Link, State Auditor Rob Sand last month released...Read More
HEALTH PLAN WEEKLY
-
For Managed Care, Democrats’ Spending Bill Is Mixed Bag
Among a slew of health care-related provisions in the most recent draft of the Build Back Better Act, the one with the biggest implications for hea...Read More -
Insurers Are Anxious to Resolve Uncertain Telehealth Policies
The COVID-19 pandemic has made virtual health care a permanent fixture of care delivery — at least as far as patients, practitioners and health pla...Read More
Radar On Speciality Pharmacy
-
Specialty Trend Increase Slows; Biosimilars Are Having Impact
In 2020, specialty trend — which consists of utilization and cost trend components — continued to increase, but it did so at a slower pace than that of the past five years...Read More -
Padcev Approval Gives Another Option to Treat Bladder Cancer
The FDA recently expanded the indication of a drug for certain types of urothelial cancer, the most common form of bladder cancer. Payers and oncologists....Read More
RADAR ON DRUG BENEFITS
-
Will Two New PBM Startups Deliver Savings, Transparency?
Two new PBMs entered the game in recent weeks: EmsanaRx, a not-for-profit venture owned by the Purchaser Business Group on Health (PBGH), and CostP...Read More -
Savings From Interchangeable Biosimilars May Be Muted
The month of October brought two important developments for interchangeable biosimilars, which industry observers have long hoped will help increas...Read More
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.